Target intelligence / Profile preview

L3MBTL histone methyl-lysine binding protein 4 (L3MBTL4)

Target
L3MBTL4
Molecular classification
Histone modification, Chromatin binding protein, Polycomb group (PcG) protein, Transcription regulator
01

Overview

**L3MBTL histone methyl-lysine binding protein 4 (L3MBTL4)** is a nuclear protein involved in chromatin organization and the negative regulation of DNA-templated transcription. It is considered a member of the Polycomb group (PcG) proteins, which are important for maintaining genes in a repressed state through chromatin modification. The gene encodes a protein of approximately 623 amino acids and is conserved across several species. L3MBTL4 has been proposed as a tumor suppressor on chromosome 18p, with gene deletion, mutation, or downregulation implicated in some cancers. It does not have known direct interacting drugs or established biomarker roles, and there are no notable safety or therapeutic concerns currently associated with direct targeting of this molecule[1][2][5][6].

Other names
Lethal(3)malignant brain tumor-like protein 4H-l(3)mbt-like protein 4L(3)mbt-like protein 4L3mbt-like 4FLJ35936HsT1031histone methyl-lysine binding protein
02

Biological functions

Chromatin organizationRegulation of transcriptionNegative regulation of DNA-templated transcription
03

Disease associations

Cancer (notably as a potential tumor suppressor)Chromosome 18p deletion syndromeBardet-Biedl syndrome 2

Beyond the preview

Go deeper on L3MBTL histone methyl-lysine binding protein 4 (L3MBTL4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L3MBTL histone methyl-lysine binding protein 4 (L3MBTL4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call